Bodycote has delivered strong share price gains in recent years, so the obvious question now is whether the current £9.17 price can still be explained by the cash the business is expected to generate. With momentum already on the board, the focus turns to what its future cash flows say about that valuation.
- Over the past 3 years the stock has returned 74.8%, which puts real weight on whether those gains align with the cash the business can produce over time.
- Bodycote runs a capital intensive industrial services operation where profitability, pricing power and asset utilisation can all affect how efficiently earnings convert into cash.
- If you'd rather focus on earnings, this one's for you. See why Bodycote's 26.5x P/E tells a different valuation story.
The stock's next move may depend on whether Bodycote's current share price is well supported by its estimated intrinsic value based on future cash flows.
If you want to cross check Bodycote against similar ideas that also focus on cash generation strength, a focused screen of 15 high quality undervalued stocks can be a useful next step.
Is Bodycote a Bargain on Cash Flow?
The Discounted Cash Flow (DCF) model for Bodycote focuses on the cash investors could receive over time from the business. Latest twelve month free cash flow sits at about £63.8 million, which gives the spreadsheet a solid starting point rather than a turnaround story. Analysts feeding the DCF expect free cash flow to be higher by 2028, with projections rising into the tens of millions over the coming decade before a slower second stage takes over.
On those assumptions, the DCF output suggests an intrinsic value that is modestly above the current £9.17 share price. That hinges on Bodycote continuing to turn a capital intensive operation into steady cash generation rather than one off surges. For readers who want to see how sensitive that picture is to different growth or discount rate inputs, the detailed DCF breakdown is one click away. Find out what Bodycote could be worth using our Discounted Cash Flow (DCF) estimate.
The Bodycote Narrative: What Would Justify Today's Price?
Narratives for Bodycote pick up where the cash flow puzzle leaves off and explain what assumptions on growth, margins and earnings would need to hold for the shares to be worth materially more or less than today’s price on Simply Wall St's Community page. Each storyline ties a fair value to a specific view of Bodycote's potential catalysts and key risks so you can track over time which version seems to be unfolding.
Community views on Bodycote split between those who think recent contract wins and cost programs still leave room in the price and those who see margin drag and bid risk crowding that upside.
Bull case: roughly fairly valued
"Major capacity expansions and upgrades in Bodycote’s U.S. aerospace and defense sites are now tied to renewed long term agreements with large Tier 1 customers…"
Discover why this Narrative puts Bodycote at roughly fairly valued.
Bear case: 15% overvalued
"The numbers implied by the current valuation leave limited allowance for ongoing auto and industrial weakness and execution risk around footprint rationalisation and bid activity…"
Explore why this Narrative puts Bodycote at 15% overvalued.
One more Bodycote check that sits beside the share price
Before parking the research, it helps to ask who is steering Bodycote and whether the pay packets at the top line up with your expectations for ownership, incentives and accountability. See who runs Bodycote and how they are paid.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com